The recipient’s ultimate goal is to advance nano-bio-manufacturing methods that could lead to large-scale fabrication of functional heart tissue, which could replace diseased or damaged muscle after a heart attack.
Researchers say these results offer further evidence that a combination of this technology and rehabilitation may help patients with spinal cord injuries regain control.
The recipients of the annual Albany Medical Center Prize in Medicine and Biomedical Research are being recognized for their contributions related to the development of the tool, called CRISPR-Cas9.
The most recent new treatment for Alzheimer’s disease was approved by European regulators in May 2002, with the US FDA following suit the next year.
Researchers at the University of Pennsylvania are getting ready to test transplanting hepatitis C-infected hearts.
The possibility of curing sepsis with a common vitamin has put one of history’s greatest killers back in the spotlight.